Liftstream is an executive search recruitment company in the life sciences sector
Mirati Therapeutics, a targeted oncology company based in San Diego, California, has promoted Vice President of Finance Jamie A. Donadio to Senior Vice President and Chief Financial Officer. In his new role, Donadio will be responsible for all corporate finance and accounting activities for the company.
Rigel Pharmaceuticals, a clinical-stage biotechnology company focused on immunology, oncology and immuno-oncology, has appointed Anne-Marie Duliege as chief medical officer to replace Elliott Grossbard, who is to retire after 14 years of service. Grossbard will remain with the company, advising on the new drug application (NDA) filing and regulatory strategy for fostamatinib in immune thrombocytopenic purpura (ITP).
PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman.
Xencor, Inc., a clinical-stage biopharmaceutical company based in California which is developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, have appointment Yujiro S. Hata to its board of directors.
Previously names Cell Therapeutics now CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) have appointment Bruce Seeley as Executive Vice President and Chief Commercial Officer, reporting to James Bianco, M.D., CTI BioPharma’s President and Chief Executive Officer. Seeley joins CTI BioPharma at the beginning of August 2015 and will serve on the executive leadership team, assuming responsibility for CTI BioPharma’s commercial organization worldwide – including sales, marketing, commercial operations, medical affairs and supply chain.
Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.